[[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxy-trimethylazanium

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 鞘脂
• 英文名称: [[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxy-trimethylazanium
• 化学式: C37H76N2O6P+
• 分子量: 676.0
• InChiKey: DWGLOHFDHLMLDQ-RQDJVNCUSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  12.6
• 重原子数：
  46
• 可旋转键数：
  34
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  105
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
  申请人：Cerenis Therapeutics Holding S.A.

  公开号：US20140213501A1

  公开（公告）日：2014-07-31

  The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
• US9187551B2
  申请人：——

  公开号：US9187551B2

  公开（公告）日：2015-11-17